Data from an open-label study conducted by the Adolescent Trials Network reminds us of the limited efficacy of PrEP among this population due to suboptimal adherence.
Young black and Latino men who have sex with men (MSM) have the highest risk for HIV infection in the U.S. However, preexposure prophylaxis (PrEP) is approved only for people aged >18 years, and PrEP studies have rarely included young, nonwhite MSM. Investigators from the Adolescent Trials Network conducted a 48-week open-label PrEP demonstration and safety study that enrolled young MSM in 12 U.S. urban centers.
Of 2186 men screened, 200 (median age, 20 years; 55% black, 27% Latino) were eligible and willing to participate; 81% reported condomless sex in the past month. The study-retention rate was 71%. Participants received a standard PrEP regimen, with monthly check-ins through week 12 and quarterly through week 48.
All three grade 3 advers…
Reviewing Author
DisclosuresGrant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; NIH/National Institute on Drug Abuse
Editorial BoardsJAIDS: Journal of Acquired Immune Deficiency Syndromes; Vaccines
Leadership Positions in Professional SocietiesInternational Antiviral Society–USA (Board of Directors); Infectious Diseases Society of America (Past President)
DisclosuresGrant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; NIH/National Institute on Drug Abuse
Editorial BoardsJAIDS: Journal of Acquired Immune Deficiency Syndromes; Vaccines
Leadership Positions in Professional SocietiesInternational Antiviral Society–USA (Board of Directors); Infectious Diseases Society of America (Past President)